Andrew Cuthbertson
Director/Board Member en ZENYTH THERAPEUTICS LIMITED .
Fortuna: 13 M $ al 31/03/2024
Perfil
En la actualidad, Andrew Cuthbertson ocupa el cargo de Director Científico y Director Ejecutivo de CSL Ltd. y Director Científico de CSL Behring LLC (una filial de CSL Ltd.). También forma parte del consejo de administración de CSL Innovation Pty Ltd., del Centre for Eye Research Australia y del Grattan Institute y es miembro del consejo de la Universidad de Melbourne. Andrew Cuthbertson ocupó anteriormente el puesto de científico principal en Genentech, Inc.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CSL LIMITED
0.01% | 16/02/2024 | 70 391 ( 0.01% ) | 13 M $ | 31/03/2024 |
Cargos activos de Andrew Cuthbertson
Empresas | Cargo | Inicio |
---|---|---|
ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - |
CSL LIMITED | Director/Board Member | 17/10/2018 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Director/Board Member | 01/01/2018 |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | 01/01/2016 |
Centre for Eye Research Australia | Director/Board Member | 01/03/2017 |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Grattan Institute develops public policy programs. The private company is based in Carlton, Australia. The CEO of the Australian company is John Daley. | Director/Board Member | 01/01/2019 |
Antiguos cargos conocidos de Andrew Cuthbertson.
Empresas | Cargo | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1997 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CSL LIMITED | Health Technology |
Empresas privadas | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
CSL Innovation Pty Ltd.
CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Centre for Eye Research Australia | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Grattan Institute develops public policy programs. The private company is based in Carlton, Australia. The CEO of the Australian company is John Daley. | Commercial Services |
- Bolsa de valores
- Insiders
- Andrew Cuthbertson